Showing results (551-560 of 887) with videos related to
Sort By:
Pageof 89
Journal of the American Society of Nephrology : JASN|November 15, 2014
Contrasting Cholesterol Management Guidelines for Adults with CKDLisandro D Colantonio, Usman Baber, Maciej Banach, et al.Diabetes, Obesity & Metabolism|January 27, 2021
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOMESubodh Verma, C David Mazer, Silvio E Inzucchi, et al.Journal of Medical Economics|July 13, 2023
Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetesPeter Rossing, Franziska Groehl, Paul Mernagh, et al.Metabolism: Clinical and Experimental|October 8, 2013
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular diseaseAndreas Tomaschitz, Eberhard Ritz, Burkert Pieske, et al.Clinical Nephrology|August 1, 2014
Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patientsEbru Sevinc Ok, Gulay Asci, Huseyin Toz, et al.Kidney International Supplements|January 25, 2019
Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological communityWim Van Biesen, Raymond Vanholder, Bert Vanderhaegen, et al.Journal of Diabetes and Its Complications|February 12, 2026
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITYRobert Weingold, Gerasimos Filippatos, Stefan D Anker, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of SGLT2 inhibitors in patients with Fabry diseaseMalte Lenders, Sima Canaan-Kühl, Christine Kurschat, et al.Clinical Kidney Journal|November 2, 2023
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)Pantelis Sarafidis, Fotini Iatridi, Charles Ferro, et al.American Journal of Hypertension|May 6, 2020
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME TrialJoão Pedro Ferreira, David Fitchett, Anne Pernille Ofstad, et al.Pageof 89